Circ‐URI1 was chosen as the target because of its upregulation in plasma EVs of patients with GC.[38] We successfully characterized the synthesized circ‐URI1 for use in subsequent experiments (Figure S1, Supporting Information). This evidence concerns the gene URI1 and gastric cancer.